| COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature A Murt, AE Eskazan, U Yılmaz, T Ozkan, MC Ar Journal of medical virology 93 (1), 43, 2021 | 67 | 2021 |
| How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review U Yilmaz, MC Ar, SN Esatoglu, I Bavunoglu, YZ Erzin, AI Hatemi, ... Annals of hematology 99, 1193-1203, 2020 | 26 | 2020 |
| COVID-19 in chronic-phase chronic myeloid leukemia patients: a single-center survey from Turkey U Yılmaz, A Pekmezci, Y Gül, AE Eşkazan Turkish Journal of Hematology 38 (1), 79, 2021 | 15 | 2021 |
| Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years? U Yilmaz, AE Eskazan Expert review of hematology 13 (10), 1035-1038, 2020 | 14 | 2020 |
| Kikuchi Fujimoto disease as the presenting component of VEXAS syndrome: a case report of a probable association U Yılmaz, S Güner, T Eşkazan, AS Demiröz, G Kurtuluş, F Bahar, S Uğurlu, ... Clinical Rheumatology 41 (11), 3589-3592, 2022 | 8 | 2022 |
| Clinical characteristics and outcomes of COVID-19 in Turkish patients with hematological malignancies S Civriz Bozdağ, G Cengiz Seval, İ Yönal Hindilerden, F Hindilerden, ... Turkish journal of haematology: official journal of Turkish Society of …, 2022 | 6 | 2022 |
| An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date U Yilmaz, A Salihoglu, T Soysal Drug Design, Development and Therapy, 3809-3820, 2021 | 5 | 2021 |
| Management of chronic myeloid leukemia in myeloid blastic phase with novel therapies: a systematic literature review U Yılmaz, B Bulan, Ç Belli, AE Eşkazan Expert Review of Hematology 15 (5), 423-429, 2022 | 3 | 2022 |
| Dermatomyositis Associated With Papillary Thyroid Cancer: Systematic Review of the Literature and a Case Report U Yilmaz, S Ugurlu JCR: Journal of Clinical Rheumatology 27 (4), 168-171, 2021 | 2 | 2021 |
| Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation N Sengul Samanci, U Yılmaz, S Bedir, N Ozgur Yurttas, K Oruc, ... Journal of Oncology Pharmacy Practice 26 (8), 2042-2046, 2020 | 2 | 2020 |
| Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase U Yılmaz, S Küçükyurt, S Tunç, AE Eşkazan Frontiers in Oncology 12, 994101, 2022 | 1 | 2022 |
| Replacing chemotherapy with arsenic trioxide for the treatment of acute promyelocytic leukemia in the frontline setting: Is it cost‐effective? U Yilmaz, AE Eskazan Cancer 126 (2), 256-259, 2020 | 1 | 2020 |
| İki Olgu Nedeniyle Bilateral İnternal Karotit Arter Tıkanması B Petik, U Yılmaz, MH Atalar, O Solak, S Topaktaş Türk Nörol Derg 10, 309-13, 2004 | 1 | 2004 |
| Chronic myeloid leukemia in renal transplantation patients in the era of tyrosine kinase inhibitors: A case report and review of the literature A Murt, B Bayram, U Yilmaz, N Seyahi, AE Eskazan Nephron, 1-1, 2024 | | 2024 |
| Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think? U Yılmaz, S Küçükyurt, MC Ar, AE Eşkazan Oncology and Therapy, 1-5, 2024 | | 2024 |
| Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma U Yılmaz, G Zulfaliyeva, AN Güzelli, D Özmen, T Elverdi, A Salihoğlu, ... Journal of Chemotherapy, 1-8, 2023 | | 2023 |
| Short-Term Clinical Outcomes of Packed Red Blood Cell Transfusions with Isolated Enzyme-Phase Crossmatch Incompatibility: A Single-Center Cross-Sectional Study U Yılmaz, A Yaşar, Ş Öngören, Z Başlar, MC Ar Turkish Journal of Hematology 40 (1), 50, 2023 | | 2023 |
| Acquired hemophilia a in adults: a multicenter study from Turkey E Arslan Davulcu, Z Demirci, U Yılmaz, MC Ar, HÜ Teke, V Karakuş, ... Indian Journal of Hematology and Blood Transfusion 39 (1), 107-115, 2023 | | 2023 |
| Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic S Küçükyurt, K Şahin, U Yılmaz, A Erçalışkan, TÖ Tekin, D Ortaboz, ... Current problems in cancer 46 (6), 100913, 2022 | | 2022 |
| Retrospective Analysis of Prognostic Factors and Survival in Multiple Myeloma Patients Aged 65 Years or Older at Diagnosis in a Real-Life Setting and a Proposed New Staging System A Tunc, M Guliyev, T Özkan Tekin, S Kucukyurt, U Yilmaz, E Kantarci, ... Blood 140 (Supplement 1), 12518-12519, 2022 | | 2022 |
